About

Andrea Cusack is the Chief Executive Officer of Nebu-Flow, responsible for transitioning the company during its growth phase and managing commercial partnerships and future collaborations. During her career she has worked at various major pharmaceutical companies and contract development and manufacturing organisations, was formerly CEO of a nanotechnology start-up, and has been associated with the launch of several major products in the respiratory, injectables, biologics and drug delivery combination space.

Contributions

PULMONARY

INNOVATIVE ACOUSTIC NEBULISER TECHNOLOGY

Andrea Cusack, Elijah Nazarzadeh and John Pritchard share insights into the company’s innovative nebuliser platform, designed to overcome the technical restrictions of current technologies that limit the delivery of advanced medicines to the lungs. They also share an update on the development of new digital features for the Nebu-Flow product range.

More contributions

SUSTAINABILITY

NANOTECHNOLOGY: A PATHWAY FOR SUSTAINABLE INNOVATION IN DRUG DEVELOPMENT

Andrea Cusack discusses how, by using bottom-up nanotechnology techniques, efficiencies can be found both in the development of new chemical entities and in the repurposing of existing drugs, and how these efficiencies translate into reduced energy requirements and therefore more sustainable industry practices.